1
A comparative study of tocopherols composition and 1
antioxidant properties of in vivo and in vitro ectomycorrhizal fungi 2
3
Filipa S. Reisa, Isabel C.F.R. Ferreiraa,*, Lillian Barrosa, Anabela Martinsb 4
5
aMountain Research Centre, CIMO-ESA, Campus de Santa Apolónia, Apartado 1172, 6
5301-854 Bragança, Portugal. 7
bSchool of Agriculture, Polytechnic Institute of Bragança, Campus de Santa Apolónia, 8
Apartado 1172, 5301-854 Bragança, Portugal. 9
10
11
* Author to whom correspondence should be addressed (e-mail: [email protected] 12
telephone +351-273-303219; fax +351-273-325405). 13
14
The work described has not been published previously; it is not under consideration for 15
publication elsewhere; its publication is approved by all authors and tacitly or explicitly 16
by the responsible authorities where the work was carried out; if accepted, it will not be 17
published elsewhere including electronically in the same form, in English or in any 18
other language, without the written consent of the copyright-holder. 19
2
ABSTRACT 1
In aerobic organisms, the free radicals are constantly being produced during the normal 2
cellular metabolism. The antioxidant properties of many organisms and particularly of 3
wild mushrooms with their content in antioxidant compounds such as tocopherols, can 4
detoxify potentially damaging forms of activated oxygen. Herein, a comparative study 5
of tocopherols composition and antioxidant properties of in vivo (fruiting bodies) and in 6
vitro (mycelia) ectomycorrhizal fungi: Paxillus involutus and Pisolithus arhizus. 7
Tocopherols were determined by high performance liquid chromatography (HPLC) 8
coupled to a fluorescence detector. The antioxidant properties were studied in terms of 9
DPPH radical-scavenging activity, reducing power and inhibition of β-carotene 10
bleaching. Fruiting bodies revealed the highest antioxidant properties, including 11
scavenging effects on free radicals (EC50 = 0.61 and 0.56 mg/ml) and inhibition of lipid 12
peroxidation capacity (EC50 = 0.40 and 0.24 mg/ml for Paxillus involutus and Pisolithus 13
arhizus, respectively), than mycelia produced in vitro cultures. Nevertheless, mycelia 14
revealed higher levels of total tocopherols than fruiting bodies, and particularly 15
Pisolithus arhizus mycelium proved to be a powerful source of γ-tocopherol (154.39 16
μg/g dry weight). 17
18
Keywords: Paxillus involutus; Pisolithus arhizus; Fruiting bodies/mycelia; Tocopherols; 19
HPLC-fluorescence; Antioxidant activity. 20
3
1. Introduction 1
Maintenance of equilibrium between free radical production and antioxidant defences 2
(enzymatic and non enzymatic) is an essential condition for normal organism 3
functioning. When this equilibrium has a tendency to the production of free radicals we 4
say that the organism is in oxidative stress. In this situation, excess free radicals may 5
damage cellular lipids, proteins and DNA, affecting his normal function and leading to 6
various diseases. In aerobic organisms, the free radicals are constantly being produced 7
during the normal cellular metabolism, mainly in the form of Reactive Oxygen Species 8
(ROS) and Reactive Nitrogen Species (RNS). The organism exposure to free radicals 9
has led to the development of endogenous defence mechanisms to eliminate them 10
(Ferreira, Barros, & Abreu, 2009; Goetz & Luch 2008; Valko et al., 2007). The 11
antioxidants present on the diet may help the endogenous defence system to reduce 12
oxidative damage (Fang, Yang, & Wu, 2002; Liu 2003; Temple, 2000). Our research 13
group has been interested in the antioxidant properties of wild mushrooms and their 14
content in antioxidant compounds such as tocopherols (Ferreira et al., 2009; Heleno, 15
Barros, Sousa, Martins, & Ferreira, 2010). 16
Tocopherols act as free radical scavengers (i.e., chain-breaking antioxidants). Only a 17
small number of published studies have compared α-tocopherol and γ-tocopherol with 18
respect to their ability to specifically inhibit nitration stress in vitro. Among four of the 19
most cited studies, three found that γ-tocopherol was a superior protectant against RNS 20
while one study found no such benefit (Hensley et al., 2004). 21
Paxillus involutus (Batsch) Fr. and Pisolithus arhizus (Scop.) Rauschert are two widely 22
used mycorrhizal mushroom species with a broad range of host plants and vast 23
application in forestry programmes of mycorrhization. Mycorrhizal fungi are symbiotic 24
organisms that establish associations with the root system of plants. This special form of 25
4
living implicates a recognizing process where chemical signals are involved and 1
oxidative stress mechanisms are most probably activated and overcome. Maintenance 2
and stress resistance of tree plantlets is considerably improved when seedlings become 3
inoculated by ectomycorrhizal fungi in the nursery (Le Tacon, 1992; Marx, Ruehle, & 4
Cordell, 1991; Rudawska & Kieliszewska-Rokicka, 1997). The establishment of 5
ectomycorrhizal symbiosis is triggered by signals produced by both partners. These 6
signals lead to morphological changes and a complex development of specific structures 7
in both the plant and the fungus (Ditengou & Lapeyrie, 2000; Heller et al., 2008; 8
Kawano, Kawano, Hosoya, & Lapeyrie, 2001; Lagrange, Jay-Allgmand, & Lapeyrie, 9
2001; Martin et al., 2001). Up and down regulation of several genes belonging to stress 10
or defense responses underlines the complex nature of the ectomycorrhizal interaction 11
(Heller et al., 2008). With these features of the mycorrhization process in mind we took 12
two mycorrhizal mushrooms to investigate their differential capacity to produce the 13
antioxidant compounds tocopherols in vivo (fruiting bodies) and after isolation in vitro 14
(mycelia). In vitro assays intend to bypass the genetic and environmentally induced 15
chemical variability of mushrooms thus enabling a continuous and homogeneous 16
production of these compounds under standard conditions. Furthermore, the in vitro 17
produced mycelia could be important sources of bioactive compounds to be used in 18
pharmaceutical or food industries. 19
20
2. Materials and methods 21
22
2.1. Mushroom species 23
Samples of Paxillus involutus (Batsch) Fr. and Pisolithus arhizus (Scop.) Rauschert 24
were collected under Castanea sativa Mill. in Bragança (Northeast Portugal), in autumn 25
5
2008. Taxonomic identification of sporocarps was made according to Benguria (1985) 1
and representative voucher specimens were deposited at the herbarium of Escola 2
Superior Agrária of Instituto Politécnico de Bragança. Macrofungi samples were 3
lyophilised (Ly-8-FM-ULE, Snijders) and reduced to a fine dried powder (20 mesh). 4
5
2.2. In vitro production of mushrooms mycelia 6
Mycelia of each one of the mushrooms were isolated from sporocarps on solid modified 7
Melin-Norkans medium (MMNm) pH 6.6 (NaCl 0.025 g/l; (NH4)2HPO4 0.25 g/l; 8
KH2PO4 0.50 g/l; FeCl3 0.0050 g/l; CaCl2 0.050 g/l; MgSO4.7H2O 0.15 g/l; thiamine 9
0.10 g/l; glucose 10 g/l; agar 20 g/l in tap water) (Marx, 1969). The strains were 10
maintained in Petri dishes (9 cm diameter) containing the same medium at 25 ºC in the 11
dark and subcultured every 4 to 6 weeks. 12
After 45 days of growth the mycelium was recovered from the medium. Both mycelium 13
and culture medium were dried separately at 30 ºC, during 24 h, and weighted to obtain 14
the dry biomass (dw). 15
16
2.3. Standards and reagents 17
The eluents n-hexane 95% and ethyl acetate 99.98% were of HPLC grade from Lab-18
Scan (Lisbon, Portugal). Methanol was of analytical grade purity and supplied by 19
Pronalab (Lisbon, Portugal). Tocopherol standards (α, β, γ and δ), trolox (6-hydroxy-20
2,5,7,8-tetramethylchroman-2-carboxylic acid) and gallic acid were purchased from 21
Sigma (St. Louis, MO, USA). Racemic tocol, 50 mg/ml, was purchased from Matreya 22
(PA, USA). 2,2-Diphenyl-1-picrylhydrazyl (DPPH) was obtained from Alfa Aesar 23
(Ward Hill, MA, USA). All other chemicals were obtained from Sigma Chemical Co. 24
6
(St. Louis, MO, USA). Water was treated in a Milli-Q water purification system (TGI 1
Pure Water Systems, USA). 2
3
2.4. Determination of tocopherols 4
Tocopherols content was determined following a procedure previously optimized and 5
described by Barros, Correia, Ferreira, Baptista, & Santos-Buelga (2008), using tocol as 6
internal standard. The equipment consisted of an integrated system with a Smartline 7
1000 pump (Knauer, Berlin, Germany), a Smartline manager 5000 degasser, an AS-8
2057 auto-sampler (Jasco, Easton, MD) and a FP-2020 fluorescence detector (Jasco, 9
Easton, MD) programmed for excitation at 290 nm and emission at 330 nm. Data were 10
analysed using Clarity DataApex 2.4 Software. The column used was a normal-phase 11
250 mm × 4.6 mm i.d., 5 μm, Polyamide II, with a 10 mm × 4 mm i.d. guard column of 12
the same material (YMC Waters, Dinslaken, Germany), operating at 30 ºC. The mobile 13
phase used was a mixture of n-hexane and ethyl acetate (70:30, v/v) at a flow rate of 1 14
ml/min. The compounds were identified by chromatographic comparisons with 15
authentic standards. Quantification was based on the fluorescence signal response, using 16
the internal standard method. Tocopherols content in the samples was expressed in µg 17
per g of dry weight. 18
19
2.5. Antioxidant activity. 20
2.5.1. General 21
The samples were extracted by stirring with methanol (1: 30 w/v; 25 ºC at 150 rpm) for 22
1 h and subsequently filtered through Whatman No. 4 paper. The residue was then re-23
extracted for 1 h. The combined methanolic extracts were evaporated at 40 ºC to 24
7
dryness and redissolved in methanol at a concentration of 50 mg/ml, and stored at 4 ºC 1
until analysis. 2
For total phenolics estimation, it was followed a spectrophotometric assay previously 3
described by the authors (Heleno et al., 2010), with measurement of absorbance at 4
765 nm. Gallic acid was used to calculate the standard curve (0.05-0.8 mM), and the 5
results were expressed as mg of gallic acid equivalents (GAE) per g of extract. 6
Chemical assays already described by the authors in previous studies (Heleno et al., 7
2010), were applied to evaluate the antioxidant activity of all samples. The extract 8
concentrations providing 50% of antioxidant activity or 0.5 of absorbance (EC50) were 9
calculated from the graphs of antioxidant activity percentages (DPPH and β-carotene 10
bleaching assays) or absorbance at 690 nm (reducing power assay) against extract 11
concentrations. Trolox was used as standard. 12
13
2.5.2. DPPH radical-scavenging activity 14
This methodology was performed using an ELX800 Microplate Reader (BioTek 15
Instruments, Inc., Winooski, VT). The reaction mixture in each one of the 96 wells 16
consisted of one of the different concentrations of the extracts (30 μl) and methanolic 17
solution (270 μl) containing DPPH radicals (6×10-5 mol/l). The mixture was kept for 60 18
min in the dark. The reduction of the DPPH radical was determined by measuring the 19
absorption at 515 nm. The radical scavenging activity (RSA) was calculated as a 20
percentage of DPPH discolouration using the equation: % RSA = [(ADPPH-AS)/ADPPH] × 21
100, where AS is the absorbance of the solution when the sample extract has been added 22
at a particular level, and ADPPH is the absorbance of the DPPH solution. 23
24
2.5.3. Reducing power 25
8
This methodology was performed using the Microplate Reader described above. The 1
different concentrations of the extracts (0.5 ml) were mixed with sodium phosphate 2
buffer (200 mmol/l, pH 6.6, 0.5 ml) and potassium ferricyanide (1% w/v, 0.5 ml). The 3
mixture was incubated at 50 ºC for 20 min, and trichloroacetic acid (10% w/v, 0.5 ml) 4
was added. The mixture (0.8 ml) was poured in the 48-wells, as also deionised water 5
(0.8 ml) and ferric chloride (0.1% w/v, 0.16 ml), and the absorbance was measured at 6
690 nm. 7
8
2.5.4. Inhibition of β-carotene bleaching. A solution of β-carotene was prepared by 9
dissolving β-carotene (2 mg) in chloroform (10 ml). Two millilitres of this solution 10
were added to a 100 ml round-bottom flask. After the chloroform was removed at 40 ºC 11
under vacuum, linoleic acid (40 mg), Tween® 80 emulsifier (400 mg), and distilled 12
water (100 ml) were added to the flask and vigorously shacked. Aliquots (4.8 ml) of this 13
emulsion were transferred into different test tubes containing different concentrations 14
(0.2 ml) of the extracts. The tubes were shaken and incubated at 50 ºC in a water bath. 15
As soon as the emulsion was added to each tube, the zero time absorbance at 470 nm 16
was measured (AnalytikJena 200 spectrophotometer). Lipid peroxidation inhibition was 17
calculated using the following equation: (β-carotene content after 2 h of assay)/(initial 18
β-carotene content) × 100. 19
20
2.6. Statistical analysis 21
For each one of the species three samples were analysed and also all the assays were 22
carried out in triplicate. The results are expressed as mean values and standard deviation 23
(SD). The results were analyzed using one-way analysis of variance (ANOVA) 24
followed by Tukey’s HSD Test with α = 0.05. This treatment was carried out using 25
9
SPSS v.16.0 software. The ANOVA results were classified using letters (different 1
letters mean significant differences among results). The letters are alphabetically 2
ordered according to the decrease of the results values. 3
4
3. Results and discussion 5
Paxillus involutus and Pisolithus arhizus mycelia grown until 37 days of inoculation. 6
Paxillus involutus mycelium started to grow only after 8 days; nevertheless its radial 7
growth was higher than the one obtained for Pisolithus arhizus (Fig. 1). 8
Fruiting bodies, mycelia and culture media of Paxillus involutus and Pisolithus arhizus 9
were analysed for their content in tocopherols and antioxidant properties. 10
Pisolithus arhizus samples, especially mycelium (158 μg/g dry weight; Table 1), 11
revealed higher total tocopherols content than Paxillus involutus due to the significant 12
contribution of γ-tocopherol (154 μg/g dry weight) (Fig. 2). For both species, mycelia 13
samples showed higher total tocopherols content than fruiting bodies and culture media. 14
The highest levels of α-tocopherol were found in Pisolithus arhizus fruiting body, while 15
the highest levels of β-tocopherol were found in Paxillus involutus mycelium, γ-16
tocopherol in Pisolithus arhizus mycelium and δ-tocopherol in Pisolithus arhizus 17
fruiting body and mycelium, and in Paxillus involutus mycelium. 18
The predominant vitamers were γ-tocopherol (Paxillus involutus fruiting body and 19
mycelium, and Pisolithus arhizus mycelium and culture medium) and β-tocopherol 20
(Paxillus involutus culture medium and Pisolithus arhizus fruiting body). 21
Tocopherols have been recognized as one of the most important antioxidants. They 22
inhibit ROS-induced generation of lipid peroxyl radicals, thereby protecting cells from 23
peroxidation of PUFA (polyunsaturated fatty acids) in membrane phospholipids, from 24
10
oxidative damage of plasma very low-density lipoprotein, cellular proteins, DNA, and 1
from membrane degeneration (Fang et al., 2002). 2
In the lipid peroxidation process, tocopherols (TOH) act as antioxidants by donating a 3
hydrogen atom to peroxyl radicals (LOO•) formed from PUFA giving a stable lipid 4
hydroperoxide (LOOH) and a tocopheroxyl radical (TO•), which reacts with other 5
peroxyl or tocopheroxyl radicals forming more stable adducts (Ferreira et al., 2009; 6
Kamal-Eldin & Appelqvist, 1996): 7
LOO• + TOH → LOOH + TO• 8
Tocopherols can also react with alkoxy radicals (LO•) formed in the propagation step 9
(LO• + TOH → LOH + TO•), or in very special cases, when oxygen is present in trace 10
amounts and hydroperoxides are present in negligible conditions, tocopherols can react 11
directlly with alkyl radicals L• (L• + TOH → LH + TO•) (Kamal-Eldin & Appelqvist, 12
1996). 13
In the past α-tocopherol was considered the most active form of vitamin E in humans 14
and it was reported as having the highest biological activity. Recent work has begun to 15
focus on so-called desmethyl tocopherols such as γ-tocopherol. Under specific 16
conditions, γ-tocopherol might scavenge RNS more efficiently than α-tocopherol and 17
thereby provide special benefits. This vitamer also reflects anti-inflammatory, 18
antineoplastic, and natriuretic functions possibly mediated through specific binding 19
interactions. Moreover, a nascent body of epidemiological data suggests that γ-20
tocopherol is a better negative risk factor for certain types of cancer and myocardial 21
infarction than is α-tocopherol (Hensley et al., 2004). Therefore, the results herein 22
obtained are very relevant once Pisolithus arhizus mycelium proved to be a powerful 23
source of γ-tocopherol. 24
The antioxidant properties of all the samples were evaluated through scavenging 25
11
activity on DPPH radicals (examined by the capacity to decrease the absorbance at 517 1
nm of DPPH solution), reducing power (evaluated measuring the conversion of a 2
Fe3+/ferricyanide complex to the ferrous form by the samples) and lipid peroxidation 3
inhibition by β-carotene-linoleate system (measured by the inhibition of β-carotene 4
bleaching, by neutralizing the linoleate-free radical and other free radicals formed in the 5
system which attack the highly unsaturated β-carotene models). The results showed an 6
increase in antioxidant properties with the increase of extract concentration (Fig. 3). 7
All the samples revealed antioxidant properties but in the order fruiting bodies > 8
mycelia > culture mediua (Table 2). Paxillus involutus fruting body revealed the highest 9
radical scavenging effects (82% at 20 mg/ml; Fig. 3) but Pisolithus arhizus fruiting 10
body gave the highest phenolics content (298 mg GAE/g extract) and the lowest EC50 11
value (0.56 mg/ml, Table 2). Concerning reducing power, Paxillus involutus mycelium 12
gave the highest absorbance at 1.25 mg/ml (1.7; Fig. 3). Both fruiting bodies gave the 13
lowest reducing power EC50 values without significant statistical differences (Table 2). 14
Pisolithus arhizus fruiting body showed the highest percentage of lipid peroxidation 15
inhibition (96% at 20 mg/ml; Fig. 3) with the lowest EC50 values without significant 16
statistical differences with Paxillus involutus fruting body sample (Table 2). 17
In fruiting bodies and culture media samples, Pisolithus arhizus revealed the highest 18
antioxidant properties, while in mycelia samples Paxillus involutus gave the highest 19
antioxidant potential. 20
Overall, fruiting bodies seem to have highest antioxidant properties, including 21
scavenging effects on free radicals and inhibition of lipid peroxidation capacity, than 22
mycelia produced in vitro cultures. Nevertheless, mycelia produced higher levels of 23
total tocopherols than fruiting bodies, and particularly Pisolithus arhizus mycelium 24
proved to be a powerful source of γ-tocopherol. 25
12
1
Acknowledgements 2
The authors are grateful to the Foundation for Science and Technology (FCT, Portugal) 3
and COMPETE/QREN/UE for financial support through the research project 4
PTDC/AGR-ALI/110062/2009. L. Barros also thanks to FCT, POPH-QREN and FSE 5
for her grant (SFRH/BPD/4609/2008). 6
7
References 8
Barros, L., Correia, D.M., Ferreira, I.C.F.R., Baptista, P., & Santos-Buelga, C. (2008). 9
Optimization of the determination of tocopherols in Agaricus sp. edible mushrooms 10
by a normal phase liquid chromatographic method. Food Chemistry, 110, 1046-1050. 11
Benguria, R.L. (1985). Mil setas ibéricas. Flash composition S.L.- Bilbao. 12
Ditengou, F.A., & Lapeyrie, F. (2000). Hypaphorine from the ectomycorrhizal fungus 13
Pisolithus arhizus counteracts activities of indole-3-acetic acid and ethylene but not 14
synthetic auxins in eucalypt seedlings. Molecular Plant-Microbe Interactions, 13, 15
151-158. 16
Fang, Y.-Z., Yang, S., & Wu, G. (2002). Free radicals, antioxidants, and nutrition. 17
Nutrition, 18, 872-879. 18
Ferreira, I.C.F.R., Barros, L., & Abreu, R.M.V. (2009). Antioxidants in wild 19
mushrooms. Current Medicinal Chemistry, 16, 1543-1560. 20
Goetz, M.E., & Luch, A. (2008). Reactive species: A cell damaging rout assisting to 21
chemical carcinogens. Cancer Letters, 266, 73-83. 22
Heleno, S.A., Barros, L., Sousa, M.J., Martins, A., & Ferreira, I.C.F.R. (2010). 23
Tocopherols composition of Portuguese wild mushrooms with antioxidant capacity. 24
Food Chemistry, 119, 1443-1450. 25
13
Heller, G., Adomas, A., Li, G., Osborne, J., Zyl, L., Sederoff, R., Finlay, R.D., Stenlid, 1
J., & Asiegbu, F.O. (2008). Transcriptional analysis of Pinus sylvestris roots 2
challenged with the ectomycorrhizal fungus Laccaria bicolor. BMC Plant Biology, 8, 3
19. 4
Hensley, K., Benaksas, E.J., Bolli, R., Comp, P., Grammas, P., Hamdheydari, L., Mou, 5
S., Pye, Q.N., Stoddard, M.F., Wallis, G., Williamson, K.S., West, M., Wechter, W.J., 6
& Floyd, R.A. (2004). New perspectives on vitamin E: γ-tocopherol and 7
carboxyethylhydroxychroman metabolites in biology and medicine. Free Radical 8
Biology and Medicine, 36, 1-15. 9
Kamal-Eldin, A., & Appelqvist, L.-A. (1996). The chemistry and antioxidant properties 10
of tocopferols and tocotrienols. Lipids, 31, 671-701. 11
Kawano, T., Kawano, N., Hosoya, H., & Lapeyrie, F. (2001). Fungal auxin antagonist 12
hypaphorine competitively inhibits indole-3-acetic acid-dependent superoxide 13
generation by horseradish peroxidase. Biochemical and Biophysical Research 14
Communications, 288, 546-551. 15
Lagrange, H., Jay-Allgmand, C., & Lapeyrie, F. (2001). Rutin, the phenolglycoside from 16
eucalyptus root exudates, stimulates Pisolithus hyphal growth at picomolar 17
concentration. New Phytologist, 149, 349-355. 18
Le Tacon F. (1992). Variations in field response of forest trees to nursery 19
ectomycorrhizal inoculation in Europe. In: Read DJ, Lewis D, Fitter A, Alexander I, 20
eds. Mycorrhizas in ecosystems. Wallington, UK: CAB International, 119-134. 21
Liu, R.H. (2003). Health benefits of fruit and vegetables are from additive and 22
synergistic combinations of phytochemicals. American Journal of Clinical Nutrition, 23
78, 517S-520S. 24
14
Martin, F., Duplessis, S., Ditengou, F., Lagrange, H., Voiblet, C., & Lapeyrie, F. (2001). 1
Developmental cross talking in the ectomycorrhizal symbiosis: signals and 2
communication genes. New Phytologist, 151, 145-154. 3
Marx, D.H. (1969). The influence of ectotrophic fungi on the resistance of pine roots to 4
pathogenic infections. I. Antagonism of mycorrhizal fungi to root pathogenic fungi 5
and soil bacteria. Phytopathology, 59, 153–163. 6
Marx, D.H., Ruehle, J.L., & Cordell, C.E. (1991). Methods for studying nursery and 7
field response of trees to specific ectomycorrhiza. Methods for studying nursery and 8
field response of trees to specific ectomycorrhiza. In: Norris JR, Read DJ, Varma AK 9
(eds.), Methods in Microbiology, 23. Academic Press, London, 384–411. 10
Rudawska, M., & Kieliszewska-Rokicka, B. (1997). Mycorrhizal formation by Paxillus 11
involutus in relation to their IAA-synthesizing activity. New Phytologist, 137, 509–12
517. 13
Temple, N.J. (2000). Antioxidants and disease: More questions than answers. Nutrition 14
Research, 20, 449-459. 15
Valko, M., Leibfritz, D., Moncol, J., Cronin, M.T.D., Mazur, M., & Telser, J. (2007). 16
Free radicals and antioxidants in normal physiological functions and human disease. 17
International Journal of Biochemistry and Cell Biology, 39, 44-84. 18
15
Figure 1. Mean radial growth of Paxillus involutus ( ) and Pisolithus arhizus ( ) in 1
MMNm (modified Melin-Norkans medium) along time of inoculation. 2
3
Figure 2. HPLC fluorescence chromatogram of Pisolithus arhizus mycelium. Peaks: 1) 4
α-tocopherol (R1=R2=CH3); 2) β-tocopherol (R1=CH3, R2=H); 3) BHT (butylated 5
hydroxytoluene); 4) γ-tocopherol (R1=H, R2=CH3); 5) δ-tocopherol (R1=R2=H); 6) I.S.- 6
internal standard (tocol). 7
8
Figure 3. Radical scavenging activity on DPPH radicals, reducing power and lipid 9
peroxidation inhibition measured by the β-carotene bleaching inhibition; mean ± SD (n 10
= 9). Paxillus involutus mycelium ( ), Paxillus involutus fruiting body ( ), Paxillus 11
involutus medium ( ), Pisolithus arhizus mycelium ( ), Pisolithus arhizus fruiting 12
body ( ), Pisolithus arhizus medium ( ). 13
14
16
Table 1. Tocopherol composition (µg/g dw); mean ± SD (n = 9). In each column
different letters mean significant differences between results (p < 0.05).
Species Sample α-tocopherol β-tocopherol γ-tocopherol δ-tocopherol Total tocopherols
Paxilus involutus Fruiting body 0.15 ± 0.01 dc 0.30 ± 0.05 f 4.27 ± 0.25 cd 0.29 ± 0.02 cb 5.02 ± 0.19 c
Paxilus involutus Mycelium 0.72 ± 0.14 b 6.18 ± 0.08 a 9.82 ± 1.40 b 1.42 ± 0.01 a 18.15 ± 1.30 b
Paxilus involutus Culture medium 0.03 ± 0.00 d 0.62 ± 0.05 e 0.39 ± 0.04 c 0.56 ± 0.03 b 1.60 ± 0.12 c
Pisolithus arhizus Fruiting body 2.11 ± 0.04 a 2.39 ± 0.33 b 1.67 ± 0.01 cd 1.68 ± 0.09 a 7.84 ± 0.45 c
Pisolithus arhizus Mycelium 0.17 ± 0.03 c 1.83 ± 0.06 c 154.39 ± 10.82 a 1.55 ± 0.40 a 157.94 ± 10.45a
Pisolithus arhizus Culture medium 0.06 ± 0.00 dc 1.28 ± 0.03 d 7.71 ± 0.26 cb 0.22 ± 0.01 c 9.28 ± 0.29 c
17
Table 2. Phenolic content (mg GAE/g extract), extraction yield (%) and antioxidant activity EC50 values (mg/ml); mean ± SD (n = 9). In each
column different letters mean significant differences between results (p < 0.05).
Species
Sample Extraction
yield
Phenolics DPPH Scavenging
activity
Reducing
power
β-carotene
bleaching inhibition
Paxilus involutus Fruiting body 34.24 ± 1.56 78.92 ± 4.47 b 0.61 ± 0.01 c 0.39 ± 0.00 e 0.40 ± 0.00 d
Paxilus involutus Mycelium 16.28 ± 0.71 59.47 ± 3.37 c 1.15 ± 0.07 b 0.65 ± 0.03 d 2.21 ± 0.12 c
Paxilus involutus Culture medium 2.27 ± 0.08 1.01 ± 0.07 e > 20.00 a 28.56 ± 0.12 a 9.85 ± 0.93 a
Pisolithus arhizus Fruiting body 20.14 ± 1.32 297.94 ± 0.30 a 0.56 ± 0.01 d 0.37 ± 0.03 e 0.24 ± 0.03 d
Pisolithus arhizus Mycelium 24.94 ± 2.81 9.48 ± 0.67 d > 20.00 a 7.29 ± 0.62 c 2.49 ± 0.18 c
Pisolithus arhizus Culture medium 0.95 ± 0.05 2.36 ± 0.07 e > 20.00 a 11.97 ± 0.01 b 4.39 ± 0.05 b
18
0.00
0.50
1.00
1.50
2.00
2.50
3.00
8 15 22 29 37 44
Days
Rad
ial G
row
th (c
m)
Fig. 1.
19
R1
HO
R2 O
Time (min)0 5 10 15 20
0
20
40
60
80
100
120
1 2
4
5 6
3Voltage(mV)
Fig. 2.
20
0
20
40
60
80
100
0 5 10 15 20
Extract concentration (mg/ml)
Scav
engi
ng e
ffect
(%)
0.00
0.50
1.00
1.50
2.00
2.50
0 5 10 15 20 25 30
Extract concentration (mg/ml)
Abs
at (
690
nm)
0
20
40
60
80
100
0 5 10 15 20
Extract concentration (mg/ml)
β-ca
rote
ne b
leac
hing
inhi
bitio
n (%
21
Fig. 3.